日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

ZNF683(+) NK cells govern chemotherapy sensitivity in advanced HPSCC via reshaping immune microenvironment.

ZNF683(+) NK 细胞通过重塑免疫微环境来控制晚期 HPSCC 的化疗敏感性。

Li Guo, Xiao Wenhao, Wu Haijun, Liu Chao, Gong Liang, Zhang Haoyu, Shao Zhuo, Bai Jing, Xia Xuefeng, Yi Xin, Wang Yunyun, Lu Shanhong, She Li, Wang Juncheng, Zhu Gangcai, Zhou Xiaojuan, Wang Wenmei, Shen Liangfang, Zhang Nu, Wang Xingwei, Huang Donghai, Hou Junwei, Qiu Yuanzheng, Zhang Xin, Hung Mien-Chie, Liu Yong

Erythropoiesis-inosine metabolic axis failure underlying retinal neurodegeneration in glaucoma: novel diagnoses and therapies.

红细胞生成-肌苷代谢轴功能障碍是青光眼视网膜神经退行性变的基础:新的诊断和治疗方法。

Chou Yuyu, Liu Wuping, Li Yanxiu, Chen Changhan, Luo Cheng, Shen Shiping, Dai Piaoyu, Feng Lemeng, Xiao Wenhao, Wang Yiyan, Wang Juncheng, Wan Linlin, Yang Zhiyu, Xie Tingting, Zhang Yujin, Kellems Rodney E, Song Weitao, Xia Xiaobo, Xia Yang

Hepatic arterial infusion chemotherapy plus sintilimab as conversion therapy for locally advanced hepatocellular carcinoma: a single-center phase II trial

肝动脉灌注化疗联合信迪利单抗作为局部晚期肝细胞癌的转化治疗:一项单中心II期试验

Pan, Yangxun; Wang, Xiaohui; Peng, Chuan; Zhao, Jing; Lu, Shixun; Zhang, Chao; Wang, Juncheng; Fu, Yizhen; Zhou, Zhongguo; Chen, Minshan; Zhang, Yaojun; Xu, Li

Survival Outcomes, Recurrence Patterns, and Its Corresponding Therapeutic Management after Conversion Therapy Followed by Curative Resection for Hepatocellular Carcinoma: A Real-World Study

转化治疗后行根治性切除术治疗肝细胞癌的生存结局、复发模式及其相应的治疗管理:一项真实世界研究

Xiao, Rui; Yang, Zhenyun; Zheng, Zehao; Liu, Na; Yu, Wei; Lin, Qingyang; Chen, Jinbin; Wang, Juncheng; Zhou, Zhongguo; Zhang, Yaojun; Chen, Minshan; Hu, Dandan

Integrated 16S rRNA Sequencing and Metabolomics Analysis Reveal the Protective Effects of (E)-Flavokawain A on AOM/DSS-Induced Colorectal Cancer in Mice

整合16S rRNA测序和代谢组学分析揭示(E)-黄酮卡文A对AOM/DSS诱导的小鼠结直肠癌的保护作用

Zhang, Xin; Wang, Di; Wang, Yang; Wang, Meimei; Wang, Juncheng; Sun, Yue; Chen, Siman; Qu, Xinting; Xia, Antong; Liu, Hongxin; Wang, Jihui; Liu, Meng

Insufficient erythrocyte-derived S1P: A pathogenic driver and diagnostic biolipid for tumor progression.

红细胞来源的 S1P 不足:肿瘤进展的致病驱动因素和诊断生物脂质。

Li Zhenjiang, Huang Weilun, Yao Zhouzhou, Wang Juncheng, Xiao Wenhao, Guo Qi, Chen Changhan, Xie Tingting, Yang Zhiyu, Liu Qingyang, Kellems Rodney E, Wu Mengzhi, Xia Yang

Correction: YTHDF2 in peritumoral hepatocytes mediates chemotherapy-induced antitumor immune responses through CX3CL1-mediated CD8+ T cell recruitment

更正:肿瘤周围肝细胞中的YTHDF2通过CX3CL1介导的CD8+ T细胞募集来介导化疗诱导的抗肿瘤免疫反应。

Yang, Zhenyun; Wang, Xin; Fu, Yizhen; Wu, Weijie; Hu, Zili; Lin, Qingyang; Peng, Wei; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Zhou, Zhongguo; Xu, Li; Zhang, Yaojun; Hou, Jiajie; Chen, Minshan

Self-assembled hole-selective contact for efficient Sn-Pb perovskite solar cells and all-perovskite tandems

用于高效锡铅钙钛矿太阳能电池和全钙钛矿串联电池的自组装空穴选择性接触

Zhu, Jingwei; Huang, Xiaozhen; Luo, Yi; Jiao, Wenbo; Xu, Yuliang; Wang, Juncheng; Gao, Zhiyu; Wei, Kun; Ma, Tianshu; You, Jiayu; Jin, Jialun; Wu, Shenghan; Zhang, Zhihao; Liang, Wenqing; Wang, Yang; Ren, Shengqiang; Wang, Changlei; Chen, Cong; Zhang, Jinbao; Zhao, Dewei

Biomaterial-assisted organoid technology for disease modeling and drug screening

生物材料辅助类器官技术在疾病建模和药物筛选中的应用

Shao, Yunyuan; Wang, Juncheng; Jin, Anqi; Jiang, Shicui; Lei, Lanjie; Liu, Liangle

Hepatic arterial infusion chemotherapy plus targeted therapy and immunotherapy versus systemic chemotherapy for advanced intrahepatic cholangiocarcinoma: a retrospective cohort study

肝动脉灌注化疗联合靶向治疗和免疫治疗与全身化疗治疗晚期肝内胆管癌的疗效比较:一项回顾性队列研究

Zheng, Zhikai; Wang, Jiongliang; Wu, Tianqing; He, Minrui; Pan, Yangxun; Wang, Juncheng; Chen, Jinbin; Hu, Dandan; Xu, Li; Zhang, Yaojun; Chen, Minshan; Zhou, Zhongguo